Trans-eQTLs can identify the downstream consequences of disease-associated variants but their effects are usually small14. To maximize power, we combined the Cortex-EUR and -AFR datasets (n = 2,759, excluding the ENA). We reduced the multiple-testing burden by focusing on 228,819 unique genetic variants, including GWAS and cis-eQTL variants.
